2009
DOI: 10.1016/j.nucmedbio.2009.01.009
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging

Abstract: We synthesized two novel CB(2) receptor PET tracers that show high affinity/selectivity for CB(2) receptors. Both tracers show favourable characteristics as radioligands for central and peripheral in vivo visualization of the CB(2) receptor and are promising candidates for primate and human CB(2) PET imaging.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
56
1
2

Year Published

2010
2010
2020
2020

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 61 publications
(61 citation statements)
references
References 33 publications
2
56
1
2
Order By: Relevance
“…However, these radioligands showed the highest brain uptake in mice (1.7 and 1.8 % ID at 2 minutes p.i., respectively) of the studied compounds [124].…”
Section: Discussionmentioning
confidence: 95%
See 3 more Smart Citations
“…However, these radioligands showed the highest brain uptake in mice (1.7 and 1.8 % ID at 2 minutes p.i., respectively) of the studied compounds [124].…”
Section: Discussionmentioning
confidence: 95%
“…The 2-oxoquinoline derivatives (NE40 (21) and 22) also showed CB 2 R specific binding in mouse and rat spleen [124]. However, in vivo human CB 2 R binding was demonstrated for both [ 11 C]GW405833 (9) and [ 11 C]NE40 (21) 2 .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…is that the tracer binds to the entire opioidergic system, thus providing a rather composite view of opioidergic neurotransmission evoked by exercise challenges. As the endocannabinoid system is also of great interest in the context of exercise research (Dietrich and McDaniel 2004 ;Sparling et al 2003 ) , future applications are awaited using novel compounds that label endocannabinoid receptors (Evens et al 2009 ;Terry et al 2008 ;Van Laere et al 2008 ) . For a detailed summary of the available opioidergic tracers, we refer to a recent review article from our group (Boecker et al 2008a ) .…”
Section: Opioid Receptor Petmentioning
confidence: 99%